146 related articles for article (PubMed ID: 35170473)
21. Sweet Syndrome: Clinical Features, Histopathology, and Associations of 83 Cases.
Casarin Costa JR; Virgens AR; de Oliveira Mestre L; Dias NF; Samorano LP; Valente NYS; Festa Neto C
J Cutan Med Surg; 2017; 21(3):211-216. PubMed ID: 28300447
[TBL] [Abstract][Full Text] [Related]
22. Histiocytoid Sweet syndrome may indicate leukemia cutis: a novel application of fluorescence in situ hybridization.
Chavan RN; Cappel MA; Ketterling RP; Wada DA; Rochet NM; Knudson R; Gibson LE
J Am Acad Dermatol; 2014 Jun; 70(6):1021-7. PubMed ID: 24636890
[TBL] [Abstract][Full Text] [Related]
23. Neutrophilic dermatoses: a review of current treatment options.
Cohen PR
Am J Clin Dermatol; 2009; 10(5):301-12. PubMed ID: 19658442
[TBL] [Abstract][Full Text] [Related]
24. Recurrent Idiopathic Sweet Syndrome - Case Report and Literature Review.
PĂtraŞcu V; Geoloaica LG; Ciurea RN
Curr Health Sci J; 2020; 46(1):90-98. PubMed ID: 32637170
[TBL] [Abstract][Full Text] [Related]
25. Histiocytoid Sweet syndrome successfully treated with etanercept.
Watson IT; Haugh I; Gardner AR; Menter MA
Proc (Bayl Univ Med Cent); 2018 Jul; 31(3):347-349. PubMed ID: 29904308
[TBL] [Abstract][Full Text] [Related]
26. Histiocytoid Sweet syndrome with haloed myeloid cells masquerading as a cryptococcal infection.
Wilson TC; Stone MS; Swick BL
Am J Dermatopathol; 2014 Mar; 36(3):264-9. PubMed ID: 23739245
[TBL] [Abstract][Full Text] [Related]
27. Histiocytoid Sweet's Syndrome: A localized cutaneous proliferation of macrophages frequently associated with chronic myeloproliferative disease.
Magro CM; Momtahen S; Nguyen GH; Wang X
Eur J Dermatol; 2015; 25(4):335-41. PubMed ID: 26067166
[TBL] [Abstract][Full Text] [Related]
28. Sweet syndrome associated with malignancies: A retrospective analysis of 25 patients from West China hospital.
Dan H; Yanmei L; Yue X; Xian J
Dermatol Ther; 2020 Jul; 33(4):e13588. PubMed ID: 32410345
[TBL] [Abstract][Full Text] [Related]
29. Sweet syndrome in patients with and without malignancy: A retrospective analysis of 83 patients from a tertiary academic referral center.
Nelson CA; Noe MH; McMahon CM; Gowda A; Wu B; Ashchyan HJ; Perl AE; James WD; Micheletti RG; Rosenbach M
J Am Acad Dermatol; 2018 Feb; 78(2):303-309.e4. PubMed ID: 29107342
[TBL] [Abstract][Full Text] [Related]
30. Sweet's syndrome (acute febrile neutrophilic dermatosis).
Burrall B
Dermatol Online J; 1999 May; 5(1):8. PubMed ID: 10673451
[TBL] [Abstract][Full Text] [Related]
31. An interesting case of pyoderma gangrenosum with immature hystiocytoid neutrophils.
Besner Morin C; Côté B; Belisle A
J Cutan Pathol; 2018 Jan; 45(1):63-66. PubMed ID: 28981149
[TBL] [Abstract][Full Text] [Related]
32. Cutaneous histiocytoid Sweet syndrome and its relationship to hematological diseases.
Bush JW; Wick MR
J Cutan Pathol; 2016 Apr; 43(4):394-9. PubMed ID: 26694973
[TBL] [Abstract][Full Text] [Related]
33. Midostaurin-induced Sweet syndrome in a patient with FLT3-ITD-positive AML.
Alkassis S; Rizwan A; Daoud L; Chi J
BMJ Case Rep; 2021 Aug; 14(8):. PubMed ID: 34417240
[TBL] [Abstract][Full Text] [Related]
34. Giant Cellulitis-Like Sweet Syndrome Masquerading As Cellulitis and Shingles: A Case Report and Literature Review.
Li W; Mian A; Zaidi K; Mahmud T
Cureus; 2023 Mar; 15(3):e36232. PubMed ID: 37069879
[TBL] [Abstract][Full Text] [Related]
35. Bortezomib-induced histiocytoid Sweet syndrome.
Murase JE; Wu JJ; Theate I; Cole GW; Barr RJ; Dyson SW
J Am Acad Dermatol; 2009 Mar; 60(3):496-7. PubMed ID: 19231647
[TBL] [Abstract][Full Text] [Related]
36. Histiocytoid sweet syndrome related to bortezomib: A mimicker of cutaneous infiltration by myeloma.
Llamas-Velasco M; Concha-Garzón MJ; Fraga J; Aragüés M
Indian J Dermatol Venereol Leprol; 2015; 81(3):305-6. PubMed ID: 25784226
[No Abstract] [Full Text] [Related]
37. Deep Sweet Syndrome Secondary to Pegfilgrastim.
Clarey D; DiMaio D; Trowbridge R
J Drugs Dermatol; 2022 Apr; 21(4):422-424. PubMed ID: 35389579
[TBL] [Abstract][Full Text] [Related]
38. Sweet syndrome as an adverse reaction to tyrosine kinase inhibitors: A review.
Yang JJ; Maloney NJ; Nguyen KA; Worswick S; Smogorzewski J; Bach DQ
Dermatol Ther; 2021 Jan; 34(1):e14461. PubMed ID: 33112465
[TBL] [Abstract][Full Text] [Related]
39. Typically atypical: histiocytoid Sweet syndrome, associated with malignancy.
Hünermund A; Wendel AM; Geissinger E; Bröcker EB; Stoevesandt J
J Dtsch Dermatol Ges; 2011 Sep; 9(9):666-9. PubMed ID: 21884413
[TBL] [Abstract][Full Text] [Related]
40. A case of neonatal sweet syndrome associated with mevalonate kinase deficiency.
Irwin M; Tanawattanacharoen VK; Turner A; Son MBF; Hale RC; Platt CD; Putra J; Schmidt BAR; Wasserman MG
Pediatr Rheumatol Online J; 2023 Sep; 21(1):101. PubMed ID: 37700301
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
